100th Patient Enrolled in ROADS Phase 3 Clinical Trial
Our enrollment of the 100th patient in the ROADS GammaTile® Clinical Trial marks a pivotal moment. This trial focuses on newly diagnosed metastatic brain tumors.
CEO Per Langoe’s Vision for GammaTile®: Interview Highlights
GT Medical Technologies’ new CEO, Per Langoe, was interviewed by MedTech Dive about his plans to partner with healthcare providers and drive the adoption of GammaTile®, the only FDA-cleared revolutionary innovation in brain brachytherapy.
Insights from Jane Steen, VP of Marketing on Point-of-Care Marketing Evolution
Vice President of Marketing, Jane Steen, shared thought-provoking insights in an interview discussing the dynamic evolution of point-of-care marketing. Explore the key highlights here.
A new radiation therapy option for patients with brain tumors
Facing glioblastoma, Gilbert Stuart found hope with GammaTile introduced by Dartmouth Hitchcock Medical Center
Should Brachytherapy Play A Key Role in the Treatment of Adult Malignant Brain Tumors?
Opinion Piece:
Yes. Brachytherapy for the treatment of intracranial malignancies holds tremendous promise for optimal management of these frequently complex patients. – Drs. Weinberg and Beckham
No. The role of brachytherapy for malignant gliomas has been well investigated and found to confer no survival benefit for patients when combined with best surgical resection and standard external radiotherapy. – Dr. Barnett
CS-131 for Operable Intracranial Neoplasms
Dr. Kotecha: Radiation therapy can be delivered to the brain externally through machines, which is called external beam radiation therapy. This is the most common approach or use in radiation therapy and some terms that you may hear that are using this type of treatment are stereotactic radiosurgery. An alternative means of delivering radiation therapy is when radiation is actually implanted into the brain itself, and that is called brachytherapy.
GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas
Neuro-Oncology Advances 2021 | Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas [published online December 27, 2021]. https://doi.org/10.1093/noajnl/vdab185
A Call for Patients to Resume Routine Cancer Screenings and Treatment
During these uncertain times, remember to proactively reach out to patients and encourage them to resume routine cancer screenings to prevent delayed diagnoses that might lead to worsened health outcomes.